About the Authors
- Christophe Richez
-
Affiliations Service de Rhumatologie, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France, UMR-CNRS 5164, Université Victor Segalen Bordeaux 2, Bordeaux, France, Department of Medicine-Renal Section, Boston University School of Medicine, Boston, Massachusetts, United States of America
- Rocco J. Richards
-
Affiliation Department of Medicine-Renal Section, Boston University School of Medicine, Boston, Massachusetts, United States of America
- Pierre Duffau
-
Affiliations UMR-CNRS 5164, Université Victor Segalen Bordeaux 2, Bordeaux, France, Service de Médecine Interne, Hôpital Saint André, CHU de Bordeaux, Bordeaux, France
- Zachary Weitzner
-
Affiliation Department of Medicine-Renal Section, Boston University School of Medicine, Boston, Massachusetts, United States of America
- Christopher D. Andry
-
Affiliation Department of Medicine-Pathology, Boston University School of Medicine, Boston, Massachusetts, United States of America
- Ian R. Rifkin
-
Affiliation Department of Medicine-Renal Section, Boston University School of Medicine, Boston, Massachusetts, United States of America
- Tamar Aprahamian
-
* E-mail: aprahami@bu.edu
Affiliation Department of Medicine-Renal Section, Boston University School of Medicine, Boston, Massachusetts, United States of America
Competing Interests
This study was funded in part by Aspreva Pharmaceuticals. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: IRR CDA TA. Performed the experiments: CR RR TA ZW. Analyzed the data: CR PD. Wrote the paper: IRR CR TA.